Skip to Content

SEC Filing Details

Document Details

Form
Filing Date
Nov 3, 2026
Document Date
Oct 30, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Regeneron Pharmaceuticals Inc.
Issuer
REGENERON PHARMACEUTICALS, INC.
Filer
GUARINI KATHRYN
Back to top